, as defined by the Food and Drug Administration (FDA), can serve diagnostic, prognostic, predictive, and pharmacodynamics purposes in cancer and other diseases. Diagnostic biomarkers are ...
Like most diseases, cancer does not have a one-treatment-cures-all solution. Patients with the same type of cancer can respond very differently to the same treatment, or respond differently over time, ...
Next-generation sequencing (NGS) has revolutionized the field of genomics by enabling researchers to generate vast amounts of sequence data in a single experiment. This technology is particularly ...
Delays in time to first lenalidomide prescription fill for multiple myeloma. Preliminary results of a combined home and rural outpatient clinic-based infusion program through the Veterans Health ...
The ICR, in collaboration with The Royal Marsden NHS Foundation Trust, has now taken delivery of the latest genome sequencing device, the NovaSeq X Plus. In this blog post, Mark Jones speaks with ...
Today, Next-Generation sequencing technologies (NGS) are an essential part of almost all life sciences research and diagnostics. Due to their quantity and especially their complexity, NGS data are ...
What people say about this course: "This was perhaps the first course where really comprehensive and complete NGS information, from A to Z, was provided. A really well-done event we would be happy to ...
News-Medical.Net on MSN
Chemotherapy-based conditioning matches outcomes of total body irradiation for MRD-negative B-ALL
In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after prior treatment, experienced comparable outcomes whether they received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback